
The aerocep has been patented worldwide in over 25 countries on 5 continents.
Fulfills the unmet need in the treatment of lower respiratory Infections, enabling diagnosis within the "golden" hour.
The modular design allows for adaptation to facilitate the whole population, ensuring friendly sampling for all patients.
The patient calmly breathes through the mouthpiece into the aerocep.
Exhaled breath is guided to the capture buffer, where biomarker-loaded aerosols are accumulating.
After sampling by the aerocep, the sample is immediately ready for point-of-care analysis.
Leave us a message
Xheal Diagnostics B.V. is a start-up company and spin-off of the Radboudumc focussed sampling innovations for the lower respiratory tract. Our proprietary exhaled breath sampling technology enables a timely and better diagnosis of lung infections and hence improves patient care.